Lifestyle and pharmacologic interventions are considered available strategies to alleviate T2DM [13], however, no specific drugs have yet been approved to treat IR even diabetes medications (such as metformin and thiazolidinediones, or thiazolidinediones) are insulin sensitizers that lower blood glucose partly by reducing IR. The gene discussed is INS; the disease is type 2 diabetes mellitus.